A rabbit model for evaluation of an extracorporeal LDL removal system.
Elevated levels of plasma low density lipoprotein cholesterol (LDL) are associated with an increased incidence of atherosclerosis and its sequelae. A decrease in LDL levels correlates with a reduction in atherosclerosis. Drug therapy and diet have been moderately successful in lowering cholesterol levels, but require significant periods of treatment. Furthermore, a patient with genetically high LDL levels, as in familial hypercholesterolemia, may need a more rapid and reliable method of decreasing serum LDL. The present study was designed to test a device which can rapidly remove LDL from the circulation. The device consists of a filter cartridge filled with semipermeable hollow fibers which have a proprietary acidic polymer (pap) immobilized on the blood/plasma contacting surfaces; this polymer has been reported to selectively bind LDL cholesterol. The device was evaluated in a hypercholesterolemic rabbit model. Reductions in LDL serum concentration, ranging from 1.4-25.3%, occurred in 6/6 studies. All animals survived the procedure. Autopsy results at 10 days showed normal histology. Binding of other proteins (HDL, albumin) were minimal and no hemolysis was observed. Results of this preliminary study demonstrate the feasibility of reducing serum LDL levels with a hollow fiber device.
Jaworek
A M
AM
Department of Surgery, New England Medical Center, Boston, Massachusetts.
Connolly
R J
RJ
Kaplan
E
E
Barry
K J
KJ
Daly
B D
BD
D000818:Animals; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D008078:Cholesterol, LDL / Q000097:blood*; D006440:Hemofiltration / Q000295:instrumentation*; D006937:Hypercholesterolemia / Q000097:blood / Q000628:therapy; D008567:Membranes, Artificial; D011817:Rabbits
D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D008567:Membranes, Artificial